All Clarivate Analytics websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.
Kala Pharmaceuticals Inc., of Waltham, Mass., raised $6.2 million in equity financing from its existing investors. The new round completes its seed financing of $11.2 million to support its pipeline in diseases affecting mucosal tissues, including cystic fibrosis.